Fig. 1From: Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy)Therapeutic strategies to target tumour-intrinsic and tumour-extrinsic mechanisms driving anti-tumour T cell dysfunctionBack to article page